Tevogen Bio secures an $8 million grant upon positive progress review, enhancing its AI-driven predictive modeling for immunotherapy. Tevogen Bio has announced that it will receive the remaining $8 ...
Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, ...
Nuvation Bio Inc. (NYSE:NUVB) is one of the Best Stocks Under $10 to Buy and Hold Forever. On March 27, Nuvation Bio Inc.
PARIS, March 09, 2026 (GLOBE NEWSWIRE) -- kyron.bio, a biotechnology company pioneering precision glycoengineering for antibody therapeutic development, today announced a strategic partnership with ...
A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s machine learning ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), announced today that it is transforming the Company to focus exclusively on the commercialization and development of Abecma ...
Vor Bio announces a $55.6 million PIPE to fund clinical trials and expects to report updated data in 2025. Vor Bio, a clinical-stage cell and genome engineering company, announced a securities ...
Today, we take a look at clinical-stage biopharma firm Gossamer Bio, whose stock is up some 175% so far in 2025. Seralutinib, Gossamer's lead asset, is advancing to late-stage development and has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results